B.Pharm with degree, diploma in Clinical Research Methodology. The candidate with a minimum 1 year experience in conducting clinical trial will be given preference.
Masters in Natural or Agricultural or Pharmaceutical Sciences, MVSc, Animal Sciences OR Bachelors degree in Engineering or Technology or Medicine from a recognized University
First Class Post Graduate Degree, including the integrated PG degree in Science, Public Health, Life Sciences OR Second Class Post Graduate Degree, including the integrated PG degree with PhD Science, Public Health, Life Sciences
Ph.D. degree in Plant Biology, Molecular Biology, Computational Biology with prior plant science research experience. Candidates who have submitted their thesis and awaiting the award of Ph.D. Degree may also apply.
Demonstrate expertise in tablet and capsule manufacturing processes, including granulation, compression, coating, and filling. Operate production equipment such as MG, FBD, compression machines, coaters, and capsule filling machines.
Leads Pharmacovigilance and Risk Management Planning and develops strategy for approach to evaluation of issues in the clinical matrix. Leads the safety component of global regulatory submissions.
The U.S. Food and Drug Administration approved Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of schizophrenia in adults. It is the first antipsychotic drug approved to treat schizophrenia that targets cholinergic receptors as opposed to dopamine receptors, which has long been the standard of care.
Recent articles have been issued in media with reference to the Central Drugs Standard Control Organization East Zone, Kolkata report referring to one batch sample of Product Shelcal 500, amongst other drugs marketed by various pharmaceutical companies, allegedly being non-standard quality.